Literature DB >> 24408017

Loss of CSMD1 or 2 may contribute to the poor prognosis of colorectal cancer patients.

Rui Zhang1, Chun Song.   

Abstract

CUB and sushi multiple domain protein 1 (CSMD1) is a candidate tumor suppressor gene. The three members of CSMD family have very similar structures, each consisting of 14 CUB domains separated from one another by a sushi domain, an additional uninterrupted array of sushi domains, a single transmembrane domain, and a short cytoplasmic tail. In this work, we aimed to study the protein and mRNA levels of the CSMD1, CSMD2, and CSMD3 and evaluate their prognostic importance in colorectal cancer. Reduced expressions of these three proteins were detected in colorectal cancer tissues by comparing matched normal tissues. Low CSMD2 expression was significantly associated with differentiation, lymphatic invasion, and tumor size. CSMD3 was associated with differentiation and lymphatic invasion. CSMD1 and CSMD2 expressions were associated with overall survival. This study offers convincing evidence for the first time that the three genes of CSMD family were downregulated in the patients with colorectal cancer and may be used as predictors of colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24408017     DOI: 10.1007/s13277-013-1581-6

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  15 in total

1.  CSMD1 exhibits antitumor activity in A375 melanoma cells through activation of the Smad pathway.

Authors:  Ming-Rui Tang; Yu-Xin Wang; Shu Guo; Si-Yuan Han; Di Wang
Journal:  Apoptosis       Date:  2012-09       Impact factor: 4.677

2.  Transcript map of the 8p23 putative tumor suppressor region.

Authors:  P C Sun; R Uppaluri; A P Schmidt; M E Pashia; E C Quant; J B Sunwoo; S M Gollin; S B Scholnick
Journal:  Genomics       Date:  2001-07       Impact factor: 5.736

3.  Loss of CSMD1 expression is associated with high tumour grade and poor survival in invasive ductal breast carcinoma.

Authors:  Mohamed Kamal; Abeer M Shaaban; Liqun Zhang; Clare Walker; Sally Gray; Nalin Thakker; Carmel Toomes; Valerie Speirs; Sandra M Bell
Journal:  Breast Cancer Res Treat       Date:  2009-08-08       Impact factor: 4.872

4.  Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing.

Authors:  Pengyuan Liu; Carl Morrison; Liang Wang; Donghai Xiong; Peter Vedell; Peng Cui; Xing Hua; Feng Ding; Yan Lu; Michael James; John D Ebben; Haiming Xu; Alex A Adjei; Karen Head; Jaime W Andrae; Michael R Tschannen; Howard Jacob; Jing Pan; Qi Zhang; Francoise Van den Bergh; Haijie Xiao; Ken C Lo; Jigar Patel; Todd Richmond; Mary-Anne Watt; Thomas Albert; Rebecca Selzer; Marshall Anderson; Jiang Wang; Yian Wang; Sandra Starnes; Ping Yang; Ming You
Journal:  Carcinogenesis       Date:  2012-04-17       Impact factor: 4.944

5.  Two patients with balanced translocations and autistic disorder: CSMD3 as a candidate gene for autism found in their common 8q23 breakpoint area.

Authors:  Chiara Floris; Stefania Rassu; Loredana Boccone; Daniela Gasperini; Antonio Cao; Laura Crisponi
Journal:  Eur J Hum Genet       Date:  2008-02-13       Impact factor: 4.246

6.  Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors.

Authors:  Pamela L Paris; Armann Andaya; Jane Fridlyand; Ajay N Jain; Vivian Weinberg; David Kowbel; John H Brebner; Jeff Simko; J E Vivienne Watson; Stas Volik; Donna G Albertson; Daniel Pinkel; Janneke C Alers; Theodorus H van der Kwast; Kees J Vissers; Fritz H Schroder; Mark F Wildhagen; Phillip G Febbo; Arul M Chinnaiyan; Kenneth J Pienta; Peter R Carroll; Mark A Rubin; Colin Collins; Herman van Dekken
Journal:  Hum Mol Genet       Date:  2004-05-11       Impact factor: 6.150

7.  Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse.

Authors:  Susan M Henshall; Daniel E H Afar; Jordan Hiller; Lisa G Horvath; David I Quinn; Krishan K Rasiah; Kurt Gish; Dorian Willhite; James G Kench; Margaret Gardiner-Garden; Phillip D Stricker; Howard I Scher; John J Grygiel; David B Agus; David H Mack; Robert L Sutherland
Journal:  Cancer Res       Date:  2003-07-15       Impact factor: 12.701

8.  CSMD1 is a novel multiple domain complement-regulatory protein highly expressed in the central nervous system and epithelial tissues.

Authors:  Damian M Kraus; Gary S Elliott; Hilary Chute; Thomas Horan; Karl H Pfenninger; Staci D Sanford; Stephen Foster; Sheila Scully; Andrew A Welcher; V Michael Holers
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

9.  Allelic imbalances and homozygous deletion on 8p23.2 for stepwise progression of hepatocarcinogenesis.

Authors:  Yutaka Midorikawa; Shogo Yamamoto; Shingo Tsuji; Naoko Kamimura; Shumpei Ishikawa; Hisaki Igarashi; Masatoshi Makuuchi; Norihiro Kokudo; Haruhiko Sugimura; Hiroyuki Aburatani
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

10.  Somatic mutations, allele loss, and DNA methylation of the Cub and Sushi Multiple Domains 1 (CSMD1) gene reveals association with early age of diagnosis in colorectal cancer patients.

Authors:  Austin Y Shull; Megan L Clendenning; Sampa Ghoshal-Gupta; Christopher L Farrell; Hima V Vangapandu; Larry Dudas; Brent J Wilkerson; Phillip J Buckhaults
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

View more
  23 in total

1.  The impact of donor and recipient common clinical and genetic variation on estimated glomerular filtration rate in a European renal transplant population.

Authors:  Caragh P Stapleton; Andreas Heinzel; Weihua Guan; Peter J van der Most; Jessica van Setten; Graham M Lord; Brendan J Keating; Ajay K Israni; Martin H de Borst; Stephan J L Bakker; Harold Snieder; Michael E Weale; Florence Delaney; Maria P Hernandez-Fuentes; Roman Reindl-Schwaighofer; Rainer Oberbauer; Pamala A Jacobson; Patrick B Mark; Fiona A Chapman; Paul J Phelan; Claire Kennedy; Donal Sexton; Susan Murray; Alan Jardine; Jamie P Traynor; Amy Jayne McKnight; Alexander P Maxwell; Laura J Smyth; William S Oetting; Arthur J Matas; Roslyn B Mannon; David P Schladt; David N Iklé; Gianpiero L Cavalleri; Peter J Conlon
Journal:  Am J Transplant       Date:  2019-03-28       Impact factor: 8.086

2.  Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early Invasive Lung Adenocarcinoma.

Authors:  Chao Zhang; Jianjun Zhang; Fang-Ping Xu; Yin-Guang Wang; Zhi Xie; Jian Su; Song Dong; Qiang Nie; Yang Shao; Qing Zhou; Jin-Ji Yang; Xue-Ning Yang; Xu-Chao Zhang; Zhi Li; Yi-Long Wu; Wen-Zhao Zhong
Journal:  J Thorac Oncol       Date:  2019-08-22       Impact factor: 15.609

3.  Clinical and Genetic Factors Associated with Cutaneous Squamous Cell Carcinoma in Kidney and Heart Transplant Recipients.

Authors:  M Lee Sanders; Jason H Karnes; Josh C Denny; Dan M Roden; T Alp Ikizler; Kelly A Birdwell
Journal:  Transplant Direct       Date:  2015-05

4.  Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer.

Authors:  Rebeca Sanz-Pamplona; Adriana Lopez-Doriga; Laia Paré-Brunet; Kira Lázaro; Fernando Bellido; M Henar Alonso; Susanna Aussó; Elisabet Guinó; Sergi Beltrán; Francesc Castro-Giner; Marta Gut; Xavier Sanjuan; Adria Closa; David Cordero; Francisco D Morón-Duran; Antonio Soriano; Ramón Salazar; Laura Valle; Victor Moreno
Journal:  Clin Cancer Res       Date:  2015-06-12       Impact factor: 12.531

5.  Evolution and heterogeneity of non-hereditary colorectal cancer revealed by single-cell exome sequencing.

Authors:  H Wu; X-Y Zhang; Z Hu; Q Hou; H Zhang; Y Li; S Li; J Yue; Z Jiang; S M Weissman; X Pan; B-G Ju; S Wu
Journal:  Oncogene       Date:  2016-12-12       Impact factor: 9.867

6.  MicroRNA-642b-3p functions as an oncomiR in gastric cancer by down-regulating the CUB and sushi multiple domains protein 1/smad axis.

Authors:  Haofeng Liu; Yuan Chen; Linsen Zhou; Xiaohui Jiang; Xiaojun Zhou
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

7.  A novel del(8)(q23.2q24.11) contributing to disease progression in a case of JAK2/TET2 double mutated chronic myelomonocytic leukemia.

Authors:  Marie Toft-Petersen; Eigil Kjeldsen; Line Nederby; Kirsten Grønbæk; Peter Hokland; Anne Stidsholt Roug
Journal:  Leuk Res Rep       Date:  2014-11-13

8.  Frequent somatic mutations in epigenetic regulators in newly diagnosed chronic myeloid leukemia.

Authors:  E Togasaki; J Takeda; K Yoshida; Y Shiozawa; M Takeuchi; M Oshima; A Saraya; A Iwama; K Yokote; E Sakaida; C Hirase; A Takeshita; K Imai; H Okumura; Y Morishita; N Usui; N Takahashi; S Fujisawa; Y Shiraishi; K Chiba; H Tanaka; H Kiyoi; K Ohnishi; S Ohtake; N Asou; Y Kobayashi; Y Miyazaki; S Miyano; S Ogawa; I Matsumura; C Nakaseko; T Naoe
Journal:  Blood Cancer J       Date:  2017-04-28       Impact factor: 11.037

9.  Identification and analysis of mutational hotspots in oncogenes and tumour suppressors.

Authors:  Hanadi Baeissa; Graeme Benstead-Hume; Christopher J Richardson; Frances M G Pearl
Journal:  Oncotarget       Date:  2017-03-28

10.  Integrative genomic and functional analysis of human oral squamous cell carcinoma cell lines reveals synergistic effects of FAT1 and CASP8 inactivation.

Authors:  Tyler F Hayes; Nathan Benaich; Stephen J Goldie; Kalle Sipilä; Ashley Ames-Draycott; Wenjun Cai; Guangliang Yin; Fiona M Watt
Journal:  Cancer Lett       Date:  2016-09-28       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.